AgNovos Healthcare
Congress Stand 69
www.agnovos.com
+1 240 753 65 00
[email protected]
AgNovos is a developer of new medical technology products leveraging regenerative medicine to address the local effects of bone disease. The Company’s first product, the OSSURE Local Osteo-Enhancement Procedure (LOEP) kit is CE-marked to form new bone in the pelvis and extremities. AgNovos is privately-held and has its corporate headquarters in New York City with manufacturing, research & development, and corporate support services located in Rockville, MD.